NCT05016297: An ongoing trial by Peking Union Medical College Hospital
This trial is ongoing. It must report results 2 weeks ago.
Full data
| Full entry on ClinicalTrials.gov | NCT05016297 |
|---|---|
| Title | A Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 14, 2022 |
| Completion date | Aug. 22, 2024 |
| Required reporting date | Aug. 22, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 4, 2025 |
| Days late | None |